13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001846368
Total reported value
$7.2B
$7.2B
107 檔
11.8%
During the Q2 2024 filing period, Simplify Asset Management Inc. (CIK: 0001846368) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $7.2B across 107 reported positions.
During Q2 2024, Simplify Asset Management Inc.'s portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 25.77% | -0.08% | -29.02% | |
| 2 | AGG | Ishares Core U.s. Aggregate | ETF-Other | 11.02% | +0.69% | +186.39% | |
| 3 | ITB | Ishares U.s. Home Constructi | ETF-Other | 7.01% | — | — | |
| 4 | AGGH | Simplify Aggregate Bond ETF | ETF-Other | 6.82% | -0.07% | — | |
| 5 | CDX | Simplify High Yield ETF | ETF-High Yield | 6.23% | — | +2599.96% | |
| 6 | BUCK | Simplify Treasury Option Inc | ETF-Gov Bonds | 5.31% | -0.06% | +1.15% | |
| 7 | EFA | Ishares Msci Eafe ETF | ETF-Other | 5.05% | — | — | |
| 8 | SLV | Ishares Silver Trust | ETF-Commodities | 4.65% | — | — | |
| 9 | MTBA | Simplify Mbs ETF | ETF-Other | 2.99% | — | — | |
| 10 | SCHP | Schwab U.s. Tips ETF | ETF-Other | 2.11% | — | — | |
| 11 | XLE | Ss Energy Select Sector | ETF-Other | 1.76% | — | — | |
| 12 | PAGP | Plains Gp Holdings Lp-cl A | Stock-Energy | 1.73% | -0.04% | — | |
| 13 | XOP | Ss Spdr S&p Og Exp & Prod | ETF-Other | 1.72% | — | -70.85% | |
| 14 | KRE | Ss Spdr S&p Regional Bank | ETF-Other | 1.63% | — | — | |
| 15 | CVNA | Carvana Co | Stock-Consumer Disc | 1.60% | — | — | |
| 16 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 1.11% | — | +15.48% | |
| 17 | APLT | Applied Therapeutics Inc | Stock-Other | 0.88% | — | — | |
| 18 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.69% | +0.01% | +41.92% | |
| 19 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 0.46% | +0.23% | +615.79% | |
| 20 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 0.46% | -0.04% | -52.58% | |
| 21 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 0.45% | -0.13% | EXIT | |
| 22 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 0.44% | — | +0.08% | |
| 23 | MRK | Merck & Co. Inc. | Stock-Healthcare | 0.43% | — | +7.63% | |
| 24 | PCT | Purecycle Technologies Inc | Stock-Other | 0.42% | +0.20% | -0.57% | |
| 25 | BSX | Boston Scientific CORP | Stock-Healthcare | 0.41% | — | +27.51% | |
| 26 | TCRX | Tscan Therapeutics Inc | Stock-Other | 0.41% | — | — | |
| 27 | AKRO | Akero Therapeutics Inc | Stock-Other | 0.39% | — | -0.08% | |
| 28 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 0.38% | +0.16% | — | |
| 29 | PHAT | Phathom Pharmaceuticals Inc | Stock-Other | 0.36% | — | — | |
| 30 | RNAGBP | Avidity Biosciences Inc | Stock-Other | 0.34% | — | — | |
| 31 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 0.30% | +0.03% | -0.57% | |
| 32 | ARDX | Ardelyx Inc | Stock-Other | 0.30% | — | +70.86% | |
| 33 | FULC | Fulcrum Therapeutics Inc | Stock-Other | 0.28% | — | -0.18% | |
| 34 | ✓ | Athira Pharma Inc | Stock-Other | 0.27% | — | — | |
| 35 | MMM | 3m Co | Stock-Industrials | 0.24% | -0.10% | EXIT | |
| 36 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.23% | +0.14% | -3.19% | |
| 37 | TSAT | Telesat CORP | Stock-Other | 0.22% | — | +25.79% | |
| 38 | TSLA | Tesla Inc | Stock-Consumer Disc | 0.22% | — | -50.27% | |
| 39 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 0.21% | — | — | |
| 40 | ✓ | Stock-Other | 0.19% | — | -57.59% | ||
| 41 | ELV | Elevance Health Inc | Stock-Healthcare | 0.19% | +0.14% | NEW | |
| 42 | MASI* | Masimo CORP | Stock-Other | 0.18% | — | +120.40% | |
| 43 | RVTY | Revvity Inc | Stock-Healthcare | 0.18% | — | -0.57% | |
| 44 | TUA | Sim St Treas Fut Strat ETF | ETF-Other | 0.15% | -0.42% | -45.53% | |
| 45 | HUM | Humana Inc | Stock-Healthcare | 0.15% | — | — | |
| 46 | CTA | Simplify Managed Futures St | ETF-Other | 0.14% | -0.07% | EXIT | |
| 47 | GBTC | Grayscale Bitcoin Trust ETF | ETF-Crypto | 0.14% | — | +23.47% | |
| 48 | ✓ | Verrica Pharmaceuticals Inc | Stock-Other | 0.14% | — | — | |
| 49 | NLY | Annaly Capital Management In | Stock-Real Estate | 0.12% | — | — | |
| 50 | COO | Cooper Cos Inc/the | Stock-Healthcare | 0.12% | — | -67.41% |
According to official SEC Form 13F filings, Simplify Asset Management Inc. reported a total U.S. public equity portfolio value of $7.2B across 107 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including IVV, AGG, ITB) accounted for 11.8% of total reported equity market value during Q2 2024.
During Q2 2024, Simplify Asset Management Inc.'s top holdings by market value included IVV (25.8%)、AGG (11.0%)、ITB (7.0%). The largest single position, IVV, represented 25.8% of total portfolio value.
In Q2 2024, Simplify Asset Management Inc. made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.